CME on ‘Neurotherapeutics: Clinical Research and Recent Advances’



Aligarh : Clinical pharmacology experts, pediatricians, neurologists and pharmaceutical scientists today updated knowledge and skills of health professionals in the Continuing Medical Education (CME) programme on ‘Neurotherapeutics: Clinical Research and Recent Advances’ of the Department of Pharmacology, Jawaharlal Nehru Medical College (JNMC), Aligarh Muslim University (AMU).

Speaking in the inaugural function at the JNMC Auditorium, Prof Tariq Mansoor (AMU Vice Chancellor) said that participation in this CME will help those in the medical field maintain competence and remain abreast with the developments in the emerging treatments for neurologic disorders, Alzheimer’s disease and related Dementias, Neurobiology, Neuropathy Disorders and early diagnosis among other topics.

“In today’s world even the younger generation is at an increased risk for several neurological and psychiatric disorders, including cognitive deficits, dementia, and seizures. This indicates the pressing need to support and perform a broad array of rigorous and important neuroscience research from fundamental studies of basic nervous system function to studies to improve treatments and prevent neurological disorders”, said AMU Vice Chancellor, Prof Tariq Mansoor.

He stressed that a dedicated Neurotherapeutics unit and a separate department should be established at JNMC for treating neurological disorders that had previously been considered untreatable.

“The programme is also opportunity to reflect on the progress in the field by focusing on promising areas for new treatment modalities”, said Prof Mohammad Gulrez (AMU Pro Vice Chancellor).

He pointed out: “The remarkable advances in genetics, biomarker development and drug discovery have led to the development of novel treatment approaches. Continued progress with newer, better therapies are needed to help people with neuropathological disorders”.

In the welcome address, Prof Rakesh Bhargava (Dean, Faculty of Medicine and Principal, JNMC) stressed: “Since vast majority of neurological disorders result in life-changing disabilities, it is extremely imperative that health workers are provided with the necessary training to make them uniquely qualified for treating the patients”.

“I strongly believe that that the contribution of this CME will be paramount to counter the exponential increase in chronic neurological disorders”, he added.

Dr Waseem Rizvi (Organising Chairman) said, “We have worked tirelessly to bring this CME on the cutting-edge work in Neurotherapeutics. It is hoped that the participants will take advantage of this opportunity to discuss some of the latest trends in clinical research and advances”.

“In the CME, highly renowned speakers are sharing, discussing, debating and dissecting significant new therapeutic drug strategies to manage challenging spectrum of diseases”, said Dr Jameel Ahmad (Organising Secretary).

On the occasion, a souvenir of the programme edited by Dr Bushra Hasan Khan was also released.

Dr Vibhu Pandey conducted the inaugural function and Dr Irfan Ahmad extended the vote of thanks.


Leave A Reply

Your email address will not be published.